(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ESSERRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ESSERRE

ST13

US500000079365506

Class

1, 5

Filing

79365506

Registration

7435507

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

08/07/2026

Trademark type

Word

Nice classes

1, 5

Filing date

12/02/2022

Registration date

07/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2024

Last transaction

08/07/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

IT

Examiner

ATTANG, UDEME U

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

ESSERRE PHARMA S.r.l.
ESSERRE PHARMA S.r.l.

Representatives

Larry H. Tronco Holland & Hart, LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical and organic compositions in the nature of fruit extracts and nutraceuticals for the manufacture of food and drink; Chemical substanceschemical materials and preparationsnatural elements being fruit extracts and nutraceuticals for use in the manufacture of food supplements and cosmetics; Chemical compounds and materials for use in sciencereagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Chemicals for use in the manufacture of pharmaceuticals; Plant extracts for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; chemicals for use in the manufacture of food supplements; Plant extracts for use in the manufacture of food supplements; plant extracts for use in the food industryplant extracts in the manufacture of foods; plant extracts for use in the manufacture of cosmetics; Botanical extractsother than essential oilsfor use in the manufacture of cosmetics

Class 5

Pharmaceutical and natural medicines for the treatment of cardiometabolic and cardiovascular risk factorsvascular diseasegastrointestinal disordersinflammation and edema of tissuesflucough and coldfatiguemalnutritionsarcopeniaimmune system deficienciesallergyhypovitaminosiscognitive impairmentmental disorderssleep disordersmusculoskeletal achesosteoarticular disordersskin disordersnails and hair disorderselectrolyte imbalancesanemiamineral deficiencyheadacheurogenital disordersgynecological disordersinfertilitydental disordershepatobiliary disorderspancreatic disordersliver diseaseobesitydiabeteseye diseaserespiratory system diseaseulcerstrauma; Food supplements and dietary preparations being dietary supplements for the treatment of cardiometabolic and cardiovascular risk factorsvascular diseasegastrointestinal disordersinflammation and edema of tissuesflucough and coldfatiguemalnutritionsarcopeniaimmune system deficienciesallergyhypovitaminosiscognitive impairmentmental disorderssleep disordersmusculoskeletal achesosteoarticular disordersskin disordersnails and hair disorderselectrolyte imbalancesanemiamineral deficiencyheadacheurogenital disordersgynecological disordersinfertilitydental disordershepatobiliary disorderspancreatic disordersliver diseaseobesitydiabeteseye diseaserespiratory system diseaseulcerstrauma; Pharmaceutical productsskin lotions and dermatological preparations

Publications

History of USPTO decisions and trademark events.

34 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/06/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/05/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/18/2024

FIMP

FINAL DISPOSITION PROCESSED

12/18/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/09/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/25/2024

GPNX

NOTIFICATION PROCESSED BY IB

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/15/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/15/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/15/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/15/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/15/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/09/2024

GNFR

FINAL REFUSAL E-MAILED

03/09/2024

CNFR

FINAL REFUSAL WRITTEN

03/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/23/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/23/2024

RFNT

REFUSAL PROCESSED BY IB

10/25/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/03/2023

RFRR

REFUSAL PROCESSED BY MPU

10/03/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/21/2023

CNRT

NON-FINAL ACTION WRITTEN

09/20/2023

DOCK

ASSIGNED TO EXAMINER

09/12/2023

MAFR

APPLICATION FILING RECEIPT MAILED

03/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/20/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/16/2023

Continuous trademark protection

Get notified about every new filing that threatens ESSERRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.